Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection.
Document Type
Journal Article
Publication Date
9-1-2016
Journal
Journal of Substance Abuse Treatment
Volume
68
Inclusive Pages
62-67
DOI
10.1016/j.jsat.2016.06.002
APA Citation
Tetrault, J., Tate, J., Edelman, E., Gordon, A., Lo Re, V., Lim, J., Rimland, D., Goulet, J., Crystal, S., Gaither, J., Gibert, C. L., Rodriguez-Barradas, M., Fiellin, L., Bryant, K., Justice, A., & Fiellin, D. (2016). Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection.. Journal of Substance Abuse Treatment, 68 (). http://dx.doi.org/10.1016/j.jsat.2016.06.002
Peer Reviewed
1